Skip to Content
Merck
All Photos(3)

Documents

SRE0013

Sigma-Aldrich

Interferon Alpha 2A human

recombinant, expressed in HEK 293 cells, ≥98% (SDS-PAGE), lyophilized powder

Synonym(s):

Interferon α 2A human, INFα2A

Sign Into View Organizational & Contract Pricing


About This Item

UNSPSC Code:
41106305
NACRES:
NA.26

recombinant

expressed in HEK 293 cells

Quality Level

Assay

≥98% (SDS-PAGE)

form

lyophilized powder

storage temp.

−20°C

Looking for similar products? Visit Product Comparison Guide

General description

IFN-α-2a belongs to the type I interferon protein family. Interferon α 2A is one among the three variants of IFN-α2. Recombinant human IFN-α-2a is expressed in human 293 cells as a glycosylated monomer of 165 amino acids, with an average molecular weight of 20 kDa (monomer).

Application

Interferon α 2A human has been used as an inhibitor of hepatitis D virus (HDV).

Biochem/physiol Actions

Interferon Alpha 2A human is produced by many cell types in response to viral infection. IFN-α-2A has antiproliferative and antitumor activities, as well as induction of apoptosis and inflammatory response
Interferon α 2A might be implicated in the regression of proliferative diabetic retinopathy. Telaprevir and pegylated interferon–α-2a (PEG-IFN–α-2a) serves as a potential therapeutic method for hepatitis C virus (HCV). IFN α 2A along with IFN α 2b and IFN α2c exhibits anti-proliferative effect.

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable


Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Telaprevir and pegylated interferon?alpha?2a inhibit wild?type and resistant genotype 1 hepatitis C virus replication in patients
Kieffer T L, et al.
Hepatology, 46(3), 631-639 (2007)
Interferon alpha-2a for proliferative diabetic retinopathy after complete laser panretinal photocoagulation treatment.
Leibovitch I, et al.
Ophthalmic Surgery, Lasers & Imaging Retina, 35(1), 16-22 (2004)
Telaprevir and pegylated interferon?alpha-2a inhibit wild-type and resistant genotype 1 hepatitis C virus replication in patients.
Tara L K, et al.
Hepatology (2007)
Antitumor activities of interferon alpha, beta, and gamma and their combinations on human melanoma cells in vitro: changes of proliferation, melanin synthesis, and immunophenotype
Garbe C, et al.
The Journal of Investigative Dermatology, 95-95 (1990)
Antitumor activities of interferon alpha, beta, and gamma and their combinations on human melanoma cells in vitro: changes of proliferation, melanin synthesis, and immunophenotype.
Garbe C, et al.
The Journal of Investigative Dermatology, 95(6), 231S-237S (1990)

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service